Loading clinical trials...

The Increase Study. Effect of Incremental Versus Fixed Pump on Peak Oxygen Consumption in Heart Failure Patients Supported With a Continuous Flow Left Venticular Assist Device | Clinical Trials | Clareo Health

COMPLETEDNA

The Increase Study. Effect of Incremental Versus Fixed Pump on Peak Oxygen Consumption in Heart Failure Patients Supported With a Continuous Flow Left Venticular Assist Device

The Increase Study. Effect of Incremental Versus Fixed Pump on Peak Oxygen Consumption in Heart Failure Patients Supported With a Continuous Flow Left Venticular Assist Device.

NCT01698398•Rigshospitalet, Denmark

View on ClinicalTrials.gov

Summary

The purpose of the study is to examine the relationship between working capacity (peak oxygen consumption) and pump speed of continuous flow left ventricular assist devices (CF-LVADs)in heart failure patients. The hypothesis is that it is possible to increase peak oxygen consumption by incrementally increasing CF-LVAD pumpspeed during exercise. The study population will consist of severe heart failure patients with CF-LVADs treated at The Heart Centre of Copenhagen University Hospital Rigshospitalet.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•HeartMate II patients who underwent surgery and follow-up at The Heart Centre of Rigshospitalet.
•Heart failure in stable phase without the need for intravenous inotropic therapy.
•Ischemic and non-ischemic cardiomyopathy.

Exclusion Criteria

•Severe aortic insufficiency.

Locations (1)

Department of Cardiology, Copenhagen University Hospital, Rigshospitalet.

Copenhagen, Denmark

Key Dates

Start Date

October 1, 2012

Primary Completion Date

January 1, 2013

Last Updated

February 11, 2014

Conditions

Heart Failure.

Interventions

Incremental pump speed of CF-LVAD.

DEVICE

Latin America Cardiac Resynchronization Therapy Study

NCT01238874

Heart Failure.

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 11, 2014Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions